Engineering the future of precision injectables.
EFX Medical Technologies is pioneering a new era in medical aesthetics and therapeutics: creating intelligent, self-contained injector technologies that bring clinical precision and safety into the hands of patients, anywhere in the world.
EFX has created a patented platform technology that combines dual-chamber auto-injector devices with size-specific facial positioning masks engineered to align each injector cell precisely over key facial muscle groups. On activation, the device automatically reconstitutes and delivers micro-doses of botulinum toxin through integrated injector cells, ensuring consistent placement, dosing accuracy, and safety - all within a closed, single-use system designed for at-home use.
Designed for licensing and co-development with pharmaceutical companies across aesthetics, dermatology, and biologics. The EFX R&D platform also supports future applications including fillers, vaccines, and needle-free volatile actives, positioning the company at the forefront of the next generation of personalised injectable medicine.
About EFX MedTech
Empowering patients with the next generation of at-home injectable technology.
Our Vision
To make precision injectable medicine as accessible and effortless as everyday skincare. By engineering intelligent, self-contained delivery systems that combine clinical accuracy with human-centred design, we aim to move treatments once confined to clinics into the hands of patients - safely, consistently, and on their own terms.
Our Innovative Approach
Our innovative approach unites engineering precision with human anatomy to create an entirely new category of injectable drug delivery. EFX MedTech’s patented system combines advanced facial-mapping algorithms with pre-calibrated delivery masks that align to key muscle groups, ensuring accurate, repeatable placement every time. Each injection site houses a self-contained dual-chamber micro-injector that automatically reconstitutes and delivers a precise dose of botulinum toxin at the moment of use - eliminating manual preparation, contamination risk, and clinical variability.
Together, these technologies enable the world’s first standardised, at-home injectable platform, translating the safety, consistency and efficacy of the clinic into a personal device.
Current R&D and Targets
Micro Auto-Injector Cell Platform
Patented dual-chamber micro-injector architecture that stores, reconstitutes, and delivers precise single doses of botulinum toxin and other biologics with pharmaceutical-grade accuracy.
At-Home Drug Delivery System
A clinically engineered, patient-operated injector and facial positioning mask that bring professional-level precision and safety into the home environment.
Broader Medical Applications
Adaptable injector technology capable of delivering a range of therapeutic and aesthetic agents, from fillers and peptides to vaccines and volatile actives.
A Global Intellectual Property Portfolio
Advancing regulatory pathways and strategic partnerships to scale EFX’s patented systems across key aesthetic and therapeutic markets worldwide.
